| [1] |
应佳栩，丘文，林慧娴，等．节律基因与肿瘤相关性研究进展[J]．中国肿瘤，2019，28(12)：927-933.
|
| [2] |
Morales-Santana S，Morell S，Leon J，et al. An overview of the polymorphisms of circadian genes associated with endocrine cancer[J]. Front Endocrinol (Lausanne)，2019，10：104.
|
| [3] |
Takahashi JS.Transcriptional architecture of the mammalian circadian clock[J]．Nat Rev Genet，2017，18(3)：164-179.
|
| [4] |
Sulli G，Manoogian ENC，Taub PR，et al.Training the circadian clock，clocking the drugs，and drugging the clock to prevent，manage，and treat chronic diseases[J]．Trends Pharmacol Sci，2018，39(9)：812-827.
|
| [5] |
Deng F，Yang K．Current status of research on the period family of clock genes in the occurrence and development of cancer[J]．J Cancer，2019，10(5)：1117-1123.
|
| [6] |
Zhao Q，Zheng G，Yang K，et al.The clock gene PER1 plays an important role in regulating the clock gene network in human oral squamous cell carcinoma cells[J]．Oncotarget，2016，7(43)：70 290-70 302.
|
| [7] |
Battaglin F，Chan P，Pan Y，et al.Clocking cancer: the circadian clock as a target in cancer therapy[J]．Oncogene，2021，40(18)：3187-3200.
|
| [8] |
Cao X，Yang Y，Selby CP，et al.Molecular mechanism of the repressive phase of the mammalian circadian clock[J]．Proc Natl Acad Sci USA，2021，118(2)：e2021174118.
|
| [9] |
Gaucher J，Montellier E，Sassone-orsi P. Molecular cogs: interplay between circadian clock and cell cycle[J]．Trends Cell Biol，2018，28(5)：368-379.
|
| [10] |
Luciano AK，Zhou W，Santana JM，et al.Clock phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues[J]．J Biol Chem，2018，293(23)：9126-9136.
|
| [11] |
Saran AR，Kalinowska D，Oh S，et al.JMJD5 links CRY1 function and proteasomal degradation[J]．PLoS Biol，2018，16(11)：e2006145.
|
| [12] |
Liu N，Zhang EE.Phosphorylation regulating the ratio of intracellular CRY1 protein determines the circadian period[J]．Front Neurol，2016，7：1159.
|
| [13] |
Tamaru T，Hirayama J，Isojima Y，et al.CK2alpha phosphorylates BMAL1 to regulate the mammalian clock[J]．Nat Struct Mol Biol，2009，16(4)：446-448.
|
| [14] |
Tsuchiya Y，Akashi M，Matsuda M，et al.Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms[J]．Sci Signal，2009，2(73)：26.
|
| [15] |
Liu Y，Hao J，Yuan G，et al.PER1 as a tumor suppressor attenuated in the malignant phenotypes of breast cancer cells[J]．Int J Gen Med，2021，14：7077-7087.
|
| [16] |
Hwang-Verslues WW，Chang PH，Jeng YM，et al.Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy[J]．Proc Natl Acad Sci USA，2013，110(30)：12 331-12 336.
|
| [17] |
Zhao H，Zeng ZL，Yang J，et al.Prognostic relevance of period1 (Per1) and period2 (Per2) expression in human gastric cancer[J]．Int J Clin Exp Pathol，2014，7(2)：619-630.
|
| [18] |
Hernandez-Rosas F，Hernandez-Oliveras A，Flores-Peredo L，et al.Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells[J]．Oncol Lett，2018，16(2)：1981-1990.
|
| [19] |
Tavano F，Pazienza V，Fontana A，et al.SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: effect of starvation[J]．Chronobiol Int，2015，32(4)：497-512.
|
| [20] |
Hasakova K，Reis R，Vician M，et al.Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression[J]．PLoS One，2019，14(10)：e0224396.
|
| [21] |
Wang X，Yan D，Teng M，et al.Reduced expression of PER3 is associated with incidence and development of colon cancer[J]．Ann Surg Oncol，2012，19(9)：3081-3088.
|
| [22] |
Wang Y，Cheng Y，Yu G，et al.Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients[J]．Onco Targets Ther，2016，9：1997-2005.
|
| [23] |
Oshima T，Takenoshita S，Akaike M，et al.Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer[J]．Oncol Rep，2011，25(5)：1439-1446.
|
| [24] |
Xiong H，Yang Y，Yang K，et al.Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer[J]．Int J Oncol，2018，52(1)：279-287.
|
| [25] |
Hsu CM，Lin SF，Lu CT，et al.Altered expression of circadian clock genes in head and neck squamous cell carcinoma[J]．Tumour Biol，2012，33(1)：149-155.
|
| [26] |
Liu B，Xu K，Jiang Y，et al.Aberrant expression of Per1，Per2 and Per3 and their prognostic relevance in non-small cell lung cancer[J]．Int J Clin Exp Pathol，2014，7(11)：7863-7871.
|
| [27] |
Xiang R，Cui Y，Wang Y，et al.Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis[J]．Oncol Rep，2018，40(5)：3040-3048.
|
| [28] |
Cao Q，Gery S，Dashti A，et al.A role for the clock gene per1 in prostate cancer[J]．Cancer Res，2009，69(19)：7619-7625.
|
| [29] |
Li Q，Xia D，Wang Z，et al.Circadian rhythm gene PER3 negatively regulates stemness of prostate cancer stem cells via WNT/beta-Catenin Signaling in tumor microenvironment[J]．Front Cell Dev Biol，2021，9：656 981.
|
| [30] |
Wang Z，Wang H，Wang Z，et al.Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders[J]．Med Oncol，2020，37(10)：90.
|
| [31] |
Chen M，Zhang L，Liu X，et al.PER1 is a prognostic biomarker and correlated with immune infiltrates in ovarian cancer[J]．Front Genet，2021，12：697471.
|
| [32] |
Zhanfeng N，Yanhui L，Zhou F，et al.Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo[J]．Oncotarget，2015，6(12)：9951-9958.
|
| [33] |
Ye H，Yang K，Tan XM，et al.Daily rhythm variations of the clock gene PER1 and cancer-related genes during various stages of carcinogenesis in a golden hamster model of buccal mucosa carcinoma[J]．Onco Targets Ther，2015，8：1419-1426.
|
| [34] |
Tan XM，Ye H，Yang K，et al.Circadian variations of clock gene Per2 and cell cycle genes in different stages of carcinogenesis in golden hamster buccal mucosa[J]．Sci Rep，2015，5：9997.
|
| [35] |
Han Y，Meng F，Venter J，et al.miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth[J]．J Hepatol，2016，64(6)：1295-1304.
|
| [36] |
Mteyrek A，Filipski E，Guettier C，et al.Clock gene Per2 as a controller of liver carcinogenesis[J]．Oncotarget，2016，7(52)：85 832-85 847.
|
| [37] |
De A，Beligala DH，Sharma VP，et al.Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks[J]．Clin Exp Metastasis，2020，37(5)：617-635.
|
| [38] |
Yang C，Wu J，Liu X，et al.Circadian rhythm is disrupted by ZNF704 in breast carcinogenesis[J]．Cancer Res，2020，80(19)：4114-4128.
|
| [39] |
Alam H，Tang M，Maitituoheti M，et al.KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer[J]．Cancer Cell，2020，37(4)：599-617.
|
| [40] |
Mocellin S，Tropea S，Benna C，et al.Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies[J]．BMC Med，2018，16(1)：20.
|
| [41] |
Lesicka M，Jablonska E，Wieczorek E，et al.Circadian gene polymorphisms associated with breast cancer susceptibility[J]．Int J Mol Sci，2019，20(22)：5704.
|
| [42] |
Dagmura H，Yigit S，Nursal AF，et al.Possible association of PER2/PER3 variable number tandem repeat polymorphism variants with susceptibility and clinical characteristics in pancreatic cancer[J]．Genet Test Mol Biomarkers，2021，25(2)：124-130.
|
| [43] |
Fu XJ，Li HX，Yang K，et al.The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells[J]．Onco Targets Ther，2016，9：2237-2245.
|
| [44] |
Cheng AY，Zhang Y，Mei HJ，et al.Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells[J]．Tumour Biol，2015，36(5)：3735-3743.
|
| [45] |
Guo X，Li K，Jiang W，et al.RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner[J]．Mol Cancer，2020，19(1)：91.
|
| [46] |
Li HX，Fu XJ，Yang K，et al.The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma[J]．Oncotarget，2016，7(15)：20 574-20 583.
|
| [47] |
Wang Z，Li L，Wang Y．Effects of Per2 overexpression on growth inhibition and metastasis，and on MTA1 nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer[J]．Mol Med Rep，2016，13(6)：4561-4568.
|
| [48] |
Zhanfeng N，Chengquan W，Hechun X，et al.Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway[J]．Oncotarget，2016，7(19)：27 350-27 362.
|
| [49] |
Gong X，Tang H，Yang K．PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex[J]．Cell Death Dis，2021，12(3)：276.
|
| [50] |
Papagiannakopoulos T，Bauer MR，Davidson SM，et al.Circadian rhythm disruption promotes lung tumorigenesis[J]．Cell Metab，2016，24(2)：324-331.
|
| [51] |
Schroll MM，LaBonia GJ，Ludwig KR，et al.Glucose restriction combined with autophagy inhibition and chemotherapy in HCT116 spheroids decreases cell clonogenicity and viability regulated by tumor suppressor genes[J]．J Proteome Res，2017，16(8)：3009-3018.
|
| [52] |
Park H，Saravanakumar G，Kim J，et al.Tumor microenvironment sensitive nanocarriers for bioimaging and therapeutics[J]．Adv Healthc Mater，2021，10(5)：e2000834.
|
| [53] |
Zhang Z，Zeng P，Gao W，et al.Circadian clock: a regulator of the immunity in cancer[J]．Cell Commun Signal，2021，19(1)：37.
|
| [54] |
Xu H，Li H，Woo SL，et al.Myeloid cell-specific disruption of period1 and period2 exacerbates diet-induced inflammation and insulin resistance[J]．J Biol Chem，2014，289(23)：16374-16388.
|
| [55] |
Wu Y，Tao B，Zhang T，et al.Pan-Cancer analysis reveals disrupted circadian clock associates with T cell exhaustion[J]．Front Immunol，2019，10：2451.
|
| [56] |
Wei W，Zhao W，Zhang Y．CBX4 provides an alternate mode of colon cancer development via potential influences on circadian rhythm and immune infiltration[J]．Front Cell Dev Biol，2021，9：669 254.
|
| [57] |
Bellet MM，Stincardini C，Costantini C，et al.The circadian protein PER1 modulates the cellular response to anticancer treatments[J]．Int J Mol Sci，2021，22(6)：2974.
|
| [58] |
Wang Z，Li F，Wei M，et al.Circadian clock protein PERIOD2 suppresses the PI3K/Akt pathway and promotes cisplatin sensitivity in ovarian cancer[J]．Cancer Manag Res，2020，12：11 897-11 908.
|
| [59] |
Wang Z，Li F，He S，et al.Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer[J]．Gene，2022，809：146 003.
|
| [60] |
Huang Z，He A，Wang J，et al.The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma[J]．Aging (Albany NY)，2021，13(12)：16 637-16 655.
|
| [61] |
Cai DW，Chen D，Sun SP，et al.Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway[J]．Eur Rev Med Pharmacol Sci，2018，22(9)：2572-2579.
|
| [62] |
Song S，Lei L，Zhang R，et al.Circadian disruption and breast cancer risk: evidence from a case-control study in china[J]．Cancers (Basel)，2023，15(2)：419.
|
| [63] |
Yang T，Huang W，Ma T，et al.The PRMT6/PARP1/CRL4B complex regulates the circadian clock and promotes breast tumorigenesis[J]．Adv Sci (Weinh)，2023，10(14)：e2202737.
|
| [64] |
Webb AJ，Harper E，Rattay T，et al.Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort[J]．EBioMedicine，2022，84：104269.
|